Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future...
Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future Directions
About this item
Full title
Author / Creator
Shaikh, Usman , Khan, Anoosha , Kumari, Priya , Ishfaq, Anzal , Ekhator, Chukwuyem , Yousuf, Paras , Halappa Nagaraj, Raghu , Raza, Hassan , Ur Rehman, Ubaid , Zaman, Mohammad Uzair , Lakshmipriya Vetrivendan, Gautham , Nguyen, Nhan , Kadel, Bijan , Sherpa, Tenzin N , Ullah, Ashraf and Bellegarde, Sophia B
Publisher
United States: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Fibrodysplasia ossificans progressiva (FOP), also known as Stoneman syndrome, is a rare genetic disorder characterized by abnormal bone development caused by activating mutations of the
gene. FOP affects both the developmental and postnatal stages, resulting in musculoskeletal abnormalities and heterotopic ossification. Current treatment options...
Alternative Titles
Full title
Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future Directions
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10378717
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10378717
Other Identifiers
ISSN
2168-8184
E-ISSN
2168-8184
DOI
10.7759/cureus.42614
